fda tirzepatide update today BREAKING NEWS!!! A weight loss drug more effective than Semaglutide has been approved by the today. (Zepbound for weight loss and Mounjaro for diabetes) showed a 15-20.9% weight change in FDA backtracks over Eli Lilly

longer-term safety in that group is not fully established

Proven Results Clinical studies show that Semaglutide users experience significant weight loss up to 15-20% of body weight in just 6-8 weeks

Manfredi-Lozano M, et al

Abstract Neurodegenerative diseases represent a major global cause of mortality and disability

NAD+ is a coenzyme, and 5-Amino-1MQ is a small molecule

Sam Altman has officially been reinstated atop OpenAI as CEO 'I have never been more excited about the future,' says Altman Sam Altman confirmed on Wednesday that he was returning to the helm at OpenAI as CEO, nearly two weeks after he was ousted from the company he co-founded